A History of Lung Cancer: The Recalcitrant Disease | Agenda Bookshop Skip to content
LAST CHANCE! Order items marked '10-20 working days' TODAY to get them in time for Christmas!
LAST CHANCE! Order items marked '10-20 working days' TODAY to get them in time for Christmas!
A01=C. Timmermann
Age Group_Uncategorized
Age Group_Uncategorized
Author_C. Timmermann
automatic-update
Category1=Non-Fiction
Category=MBX
Category=MJCL
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€50 to €100
PS=Active
softlaunch

A History of Lung Cancer: The Recalcitrant Disease

★★★★★
★★★★★

English

By (author): C. Timmermann

The first comprehensive history of lung cancer from around 1800 to the present day; a story of doctors and patients, hopes and fears, expectations and frustrations. Where most histories of medicine focus on progress, Timmermann asks what happens when medical progress does not seem to make much difference. See more
€97.84
€102.99
Save 5%
A01=C. TimmermannAge Group_UncategorizedAuthor_C. Timmermannautomatic-updateCategory1=Non-FictionCategory=MBXCategory=MJCLCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€50 to €100PS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Dimensions: 140 x 216mm
  • Publication Date: 20 Nov 2013
  • Publisher: Palgrave USA
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9781403988027

About C. Timmermann

Carsten Timmermann is a Lecturer at the Centre for the History of Science Technology and Medicine University of Manchester UK. He is the editor (with Elizabeth Toon) of Cancer Patients Cancer Pathways: Historical and Sociological Perspectives (Palgrave Macmillan 2012) and (with Julie Anderson) of Devices and Designs: Medical Technologies in Historical Perspective (Palgrave Macmillan 2006).

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept